Product
MEDI-570
1 clinical trial
11 indications
Indication
Cutaneous T-Cell LymphomaIndication
Angioimmunoblastic T-Cell LymphomaIndication
Follicular LymphomaIndication
Grade 2 Follicular LymphomaIndication
Mycosis FungoidesIndication
Cutaneous T-Cell Non-Hodgkin LymphomaIndication
Stage III Mycosis Fungoides AJCC v7Clinical trial
A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)Status: Active (not recruiting), Estimated PCD: 2023-08-04